Kathleen (Kate) MacQueen, PhD, MPH, a senior scientist at FHI 360, has been named to the Behavioral and Social Sciences Approaches to Preventing HIV/AIDS (BSPH) study section of the Center for Scientific Review at the U.S. National Institutes of Health (NIH) in Bethesda, MD. Dr. MacQueen will help to ensure the quality of the NIH peer-review process.

“I am honored to be invited to serve on one of NIH’s study sections and to contribute in this way to advancing HIV prevention at our nation’s leading research institution,” said Dr. MacQueen.

With advanced degrees in anthropology and health behavior, Dr. MacQueen serves in the Social and Behavioral Health Sciences department within the Global Health, Population and Nutrition group at FHI 360. Her areas of expertise include social, behavioral and ethical aspects of biomedical HIV prevention trials; community-based participatory research; stakeholder engagement; mixed-methods research; and gender dynamics.

In addition to her work at FHI 360, Dr. MacQueen serves as Adjunct Associate Professor in Health Behavior at the Gillings School of Global Public Health and Social Medicine, School of Medicine, at the University of North Carolina at Chapel Hill. She previously served as a research anthropologist and science director in the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention at the U.S. Centers for Disease Control and Prevention.

A founding member of the Association for the Social Sciences and Humanities in HIV, Dr. MacQueen has also served as an advisor to groups involved in a wide range of social science and ethics activities, including the HIV Prevention Trials Network Ethics Working Group, the Steering Committee for UNAIDS consultations on Ground Rules for HIV Prevention, the UNAIDS Expert Panel on Revising the 2000 Guidance Document “Ethical Considerations in HIV Preventive Vaccine Research,” and an external portfolio review of the trans-NIH AIDS-related behavioral and social science research program.
 
Dr. MacQueen’s recent research includes leading LinCS 2 Durham, a five-year NIH-funded research project to build support for HIV prevention work with African-American communities in Durham, North Carolina. The project focuses specifically on young adults, development of a framework for evaluating Good Participatory Practices in TB Drug Trials globally and social analyses of women’s adherence to emerging HIV prevention technologies, including tenofovir gel and vaginal rings.